More than 80 A-share companies submitted applications to the Hong Kong Stock Exchange within this year.

Recently, following the A-share restructuring of the leading protein drug company Kexing Pharmaceutical's Hong Kong listing, the A-share medical device leader Mindray Medical has also formally submitted an application for listing on the Hong Kong Stock Exchange. According to incomplete statistics, there have been more than 80 A-share listed companies submitting applications for Hong Kong listing this year. With companies like Siles, Jushi Electronics and other A-share companies consecutively listing in Hong Kong, the number of companies achieving "A+H" listings has reached 16 this year, with the total number of "A+H" listed companies exceeding 160.